Cadegiani FA. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? Am J Physiol Endocrinol Metab 318: E587–E588, 2020; doi: 10.1152/ajpendo.00136.2020. The present address of F. A. Cadegiani is Corpometria Institute, Brasilia, DF, Brazil.